Low KLF11 expression was associated with poor prognosis and poor chemotherapy response in sarcoma patients, and as a TGF-β signaling pathway mediator, KLF11 could be a druggable suppressor for sarcoma cancer stem cells [54]. Here, TGFB1 is linked to sarcoma.